Recent News
Hernia Mesh Lawsuits Mount, as Tennessee Plaintiff Seeks Compensation for Atrium C-Qur Complications
Hernia mesh lawsuits continue to mount in courts throughout the country, as a woman from Tennessee became one of the most recent plaintiffs to seek compensation for injuries and complications allegedly associated with Atrium Medical Corp’s C-Qur hernia patch. Atrium … Continue reading
Another AndroGel Testosterone Lawsuit Heads to Trial in May
The federal court overseeing thousands of testosterone lawsuits filed on behalf of men who claim their use of AndroGel caused heart attacks, strokes and blood clots is preparing to convene its next bellwether trial next month. AndroGel Pulmonary Embolism Testimony … Continue reading
Proton Pump Inhibitor Lawsuit Attorneys Seek to Bundle 300 Plaintiffs in Single Complaint
Proton pump inhibitor lawsuits continue to move forward in the federal litigation currently underway in New Jersey, where plaintiffs’ attorneys recently requested permission to temporarily bundle up to 300 individual claims in a single complaint. Proposal Asserts Temporary Bundling Will … Continue reading
Talcum Powder Class Action Lawsuit Accuses Johnson & Johnson of Concealing Alleged Cancer Risk
A new class action lawsuit is accusing Johnson & Johnson of neglecting to warn consumers of the alleged link between its popular talcum powder products and ovarian cancer. The complaint, which was filed on February 27th in Madison County Circuit … Continue reading
Tasigna Approved for Use in Children Amid Growing Arteriosclerosis Lawsuit Filings
The U.S. Food & Drug Administration (FDA) has cleared Tasigna for use in children, even as a growing number of lawsuits accuse its manufacturer of downplaying the drug’s alleged link to arteriosclerosis and related complications. Tasigna (nilotinib) belongs to a … Continue reading
Onglyza Lawsuits Mount, as Kentucky Woman Files New Heart Failure Case
A Kentucky woman who developed heart failure after being prescribed Onglyza and Kombiglyze XR to treat her Type 2 diabetes has become one of the latest plaintiffs to take legal action against AstraZeneca and Bristol-Myers Squibb. Lawsuit Alleges Onglyza, Kombiglyze … Continue reading
Diabetes Drug Lawsuits Involving Byetta, Januvia, and Victoza Move Forward, as Federal Court Adopts New Bellwether Trial Schedule for Pancreatic Cancer Claims
Diabetes drug lawsuits filed against the manufacturers of Byetta, Januvia and Victoza are moving forward once again, as a federal court housing hundreds of pancreatic cancer claims recently adopted a new schedule that could allow bellwether trials to begin in … Continue reading
Follow Us
